BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38400673)

  • 21. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
    Appelhoff RJ; Tian YM; Raval RR; Turley H; Harris AL; Pugh CW; Ratcliffe PJ; Gleadle JM
    J Biol Chem; 2004 Sep; 279(37):38458-65. PubMed ID: 15247232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolyl Hydroxylase 3 Knockdown Accelerates
    Zacharias NM; Wang L; Maity T; Li L; Millward SW; Karam JA; Wood CG; Navai N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-Inducible Factor 2a Expression Is Positively Correlated With Gleason Score in Prostate Cancer.
    Pavlakis D; Kampantais S; Gkagkalidis K; Gourvas V; Memmos D; Tsionga A; Dimitriadis G; Vakalopoulos I
    Technol Cancer Res Treat; 2021; 20():1533033821990010. PubMed ID: 33752529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reciprocal regulation between hypoxia-inducible factor-1alpha and its prolyl hydroxylases in hypoxic pulmonary hypertension rats].
    Chen YR; Dai AG; Hu RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):668-73. PubMed ID: 17129494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
    Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
    J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
    Astuti D; Ricketts CJ; Chowdhury R; McDonough MA; Gentle D; Kirby G; Schlisio S; Kenchappa RS; Carter BD; Kaelin WG; Ratcliffe PJ; Schofield CJ; Latif F; Maher ER
    Endocr Relat Cancer; 2011 Feb; 18(1):73-83. PubMed ID: 20959442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins
    Koren A; Rijavec M; Krumpestar T; Kern I; Sadikov A; Čufer T; Korošec P
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
    Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
    Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
    Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
    Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
    Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
    Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of HIF-prolyl 4-hydroxylases 1, 2 and 3 in NG2-expressing cells induces HIF2-mediated neurovascular expansion independent of erythropoietin.
    Urrutia AA; Guan N; Mesa-Ciller C; Afzal A; Davidoff O; Haase VH
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13547. PubMed ID: 32846048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
    Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
    Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.
    Minamishima YA; Moslehi J; Padera RF; Bronson RT; Liao R; Kaelin WG
    Mol Cell Biol; 2009 Nov; 29(21):5729-41. PubMed ID: 19720742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.
    Yan M; Rayoo M; Takano EA; ; Fox SB
    Br J Cancer; 2009 Oct; 101(7):1168-74. PubMed ID: 19724277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys.
    Broeker KAE; Fuchs MAA; Schrankl J; Lehrmann C; Schley G; Todorov VT; Hugo C; Wagner C; Kurtz A
    J Physiol; 2022 Feb; 600(3):671-694. PubMed ID: 34863041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential and reciprocal regulation between hypoxia-inducible factor-alpha subunits and their prolyl hydroxylases in pulmonary arteries of rat with hypoxia-induced hypertension.
    Chen YR; Dai AG; Hu RC; Jiang YL
    Acta Biochim Biophys Sin (Shanghai); 2006 Jun; 38(6):423-34. PubMed ID: 16761101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
    Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
    J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.
    Högel H; Rantanen K; Jokilehto T; Grenman R; Jaakkola PM
    PLoS One; 2011; 6(11):e27112. PubMed ID: 22087251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.